Company recalls sodium chloride for injection
B. Braun Medical Inc. has recalled five lots of 0.9% sodium chloride for injection due to fluid leakage or low fill volume, which could pose an infection risk to patients, the Food and Drug Administration announced last week. The company has not received reports of any adverse events. Hospitals and other facilities should immediately stop using the recalled products, and may report any adverse reactions or quality problems to the FDA’s MedWatch program.
Related News Articles
Headline
The Food and Drug Administration is evaluating Chinese-made plastic syringes used to inject or withdraw fluids from the body, citing concern that they may…
Headline
Draeger Medical, Inc. is recalling its Carina Ventilators due to the presence of contaminants in the device’s airpath, which exceed acceptable levels if…
Headline
Crews are working to restore power and assess damage to a Pfizer plant in North Carolina that makes sterile injectables for U.S. hospitals after a tornado…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
The Consumer Financial Protection Bureau, Centers for Medicare & Medicaid Services, Department of Health and Human Services, and Department of the Treasury…
Headline
As urged by the AHA and its professional membership group the Association for Health Care Resource & Materials Management, the Food and Drug Administration…